Some biopharma business development teams had a sleepless weekend. Four healthcare-related acquisitions were announced in quick succession on Monday morning, totaling about $18 billion …
In a research report issued today, Canaccord Genuity analyst Corey Davis reiterated a Hold rating on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) with a …
